ISRG targets fast-growing ambulatory surgery centers with lower-cost da Vinci systems, positioning for long-term procedure growth as care shifts beyond hospitals.
Bamco Inc. NY lessened its stake in Intuitive Surgical, Inc. (NASDAQ: ISRG) by 1.1% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 99,633 shares of the medical equipment provider's stock after selling 1,140 shares during the quarter.
Ameriprise Financial Inc. lifted its position in shares of Intuitive Surgical, Inc. (NASDAQ: ISRG) by 1.2% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,674,479 shares of the medical equipment provider's stock after acquiring an additional 19,552
FORA Capital LLC purchased a new stake in Intuitive Surgical, Inc. (NASDAQ: ISRG) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 10,610 shares of the medical equipment provider's stock, valued at approximately $4,745,000. Intuitive Surgical makes up about 0.8% of
Banque Transatlantique SA boosted its stake in Intuitive Surgical, Inc. (NASDAQ: ISRG) by 18.9% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 160,131 shares of the medical equipment provider's stock after purchasing an additional 25,462 shares during the period. Intuitive
2Xideas AG raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ: ISRG) by 11.4% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 10,764 shares of the medical equipment provider's stock after buying an additional 1,102 shares during the
In the closing of the recent trading day, Intuitive Surgical, Inc. (ISRG) stood at $472.16, denoting a -1.48% move from the preceding trading day.
The average of price targets set by Wall Street analysts indicates a potential upside of 29.7% in Intuitive Surgical (ISRG). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Zacks.com users have recently been watching Intuitive Surgical (ISRG) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
In the latest trading session, Intuitive Surgical, Inc. (ISRG) closed at $479.27, marking a -2.76% move from the previous day.
ISRG targets cardiac surgery as a long-term da Vinci 5 growth driver after FDA clearance, eyeing nearly 160,000 potential procedures in cleared markets vs approximately 17,000 today.